Mark Verlander
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 5%
- Genetic Associations and Epidemiology
Papers in
-
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 1
- Genetics 6
- Genetic Associations and Epidemiology 6
- Co-authors
- James Allan (1 shared paper)Imran I. Patel (1 shared paper)Bronagh Blackwood (1 shared paper)Daniel Francis McAuley (1 shared paper)Shondipon Laha (1 shared paper)
- Journals
- JAMA (5 papers)Nature (4 papers)The Lancet Respiratory Medicine (1 paper)Critical Care (1 paper)Intensive Care Medicine (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Mark Verlander
13 papers receiving 1.6k citations
Mark Verlander's Hit Papers
Peers
Comparison fields: 5 of 87
- Infectious Diseases 849
- Genetics 504
- Neurology 87
- Internal Medicine 18
- Immunology 103
Countries citing papers authored by Mark Verlander
This map shows the geographic impact of Mark Verlander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Verlander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Verlander more than expected).
Fields of papers citing papers by Mark Verlander
This network shows the impact of papers produced by Mark Verlander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Verlander. The network helps show where Mark Verlander may publish in the future.
Co-authors
The 5 scholars most cited alongside Mark Verlander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 3 | 2021 | 166 | |
| 4 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 5 | 2022 | 105 | |
| 6 | 2022 | 100 | |
| 7 | 2021 | 72 | |
| 8 | 2023 | 60 | |
| 9 | 2023 | 46 | |
| 10 | 2021 | 43 | |
| 11 | 2023 | 34 | |
| 12 | 2023 | 9 | |
| 13 | 2024 | 8 | |
| 14 | 2021 | 0 |
About Mark Verlander
Mark Verlander is a scholar working on Infectious Diseases, Genetics, Occupational Therapy, Nutrition and Dietetics and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), Genetic Associations and Epidemiology (6 papers), Speech Recognition and Synthesis (1 paper), Assistive Technology in Communication and Mobility (1 paper), Respiratory Support and Mechanisms (1 paper), Vitamin C and Antioxidants Research (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Infectious Diseases (849 citations), Genetics (504 citations), Neurology (87 citations), Internal Medicine (18 citations) and Immunology (103 citations). Mark Verlander has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include James Allan, Imran I. Patel, Bronagh Blackwood, Daniel Francis McAuley and Shondipon Laha. Their work appears in journals such as JAMA, Nature, The Lancet Respiratory Medicine, Critical Care and Intensive Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.